Immuno-engineered mitochondria for efficient therapy of acute organ injuries via modulation of inflammation and cell repair

Acute organ injuries are a major public health concern, driven by inflammation and mitochondrial dysfunction, leading to cell damage and organ failure. In this study, we engineered neutrophil membrane-fused mitochondria (nMITO), which combine the injury-targeting and anti-inflammatory properties of neutrophil membrane proteins with the cell-repairing function of mitochondria. nMITO effectively blocked inflammatory cascades and restored mitochondrial function, targeting both key mechanisms in acute organ injuries. Additionally, nMITO selectively targeted damaged endothelial cells via β-integrins and was delivered to injured tissues through tunneling nanotubes, enhancing their regulatory effects on inflammation and cell damage. In mouse models of acute myocardial injury, liver injury, and pancreatitis, nMITO significantly reduced immune dysfunction and repaired tissue damage. These findings suggest that nMITO is a promising therapeutic strategy for managing acute organ injuries.